• Further attempts to induce immunological tolerance in 29 psoriatic patients treated topically with mechlorethamine hydrochloride have not been successful using the intravenous route. The rate of sensitization achieved (65%) is not substantially different from the rate for those patients who had no attempt to induce tolerance (55.5%).
(Arch Dermatol 111:1438-1439, 1975)
Breza TS, Kechijian P, Taylor JR. Mechlorethamine in Psoriasis: Further Attempts to Induce Immunological Tolerance. Arch Dermatol. 1975;111(11):1438–1439. doi:10.1001/archderm.1975.01630230040005
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.